VIPADENANT

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H15N7O
Molecular Weight	321.3366
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of VIPADENANT

Structure Search

SMILES

CC1=CC(CN2N=NC3=C2N=C(N)N=C3C4=CC=CO4)=CC=C1N

InChI

InChIKey=HQSBCDPYXDGTCL-UHFFFAOYSA-N

InChI=1S/C16H15N7O/c1-9-7-10(4-5-11(9)17)8-23-15-14(21-22-23)13(19-16(18)20-15)12-3-2-6-24-12/h2-7H,8,17H2,1H3,(H2,18,19,20)

HIDE SMILES / InChI

Molecular Formula	C16H15N7O
Molecular Weight	321.3366
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 17:49:27 UTC 2023` Edited by `admin` on `Sat Dec 16 17:49:27 UTC 2023`
Record UNII	LDR3USH1NJ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VIPADENANT

Official Name

English

VER-A00049

Code

English

VER-11135

Code

English

V2006

Code

English

VER-A-00049

Code

English

vipadenant [INN]

Common Name

English

Vipadenant [WHO-DD]

Common Name

English

3-((4-AMINO-3-METHYLPHENYL)METHYL)-7-(FURAN-2-YL)-3H-(1,2,3)TRIAZOLO(4,5-D)PYRIMIDIN-5-AMINE

Systematic Name

English

VER-A-00-11

Code

English

BIIB014

Code

English

VER-A00-11

Code

English

V-2006

Code

English

3H-1,2,3-TRIAZOLO(4,5-D)PYRIMIDIN-5-AMINE, 3-((4-AMINO-3-METHYLPHENYL)METHYL)-7-(2-FURANYL)-

Systematic Name

English

CEB-4520

Code

English

VIPADENANT [USAN]

Common Name

English

BIIB-014

Code

English

VER-ADO-49

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C38149

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

NCI_THESAURUS

C2139

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

Code System Code Type Description

INN

9329

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

FDA UNII

LDR3USH1NJ

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

CAS

442908-10-3

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

ChEMBL

CHEMBL3545386

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

ChEMBL

CHEMBL447664

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

NCI_THESAURUS

C152892

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

EPA CompTox

DTXSID90196103

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

CAS

1148126-34-4

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

SUPERSEDED

SMS_ID

300000034483

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

USAN

WW-153

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

PUBCHEM

21874557

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

CAS

874193-81-4

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

SUPERSEDED

DRUG BANK

DB06625

Created by admin on Sat Dec 16 17:49:27 UTC 2023 , Edited by admin on Sat Dec 16 17:49:27 UTC 2023

PRIMARY

Related Record Type Details


					Y154T023U0

ADENOSINE RECEPTOR A2A

TARGET -> INHIBITOR

Related Record Type Details


					LDR3USH1NJ

ACTIVE MOIETY